CPC A61K 39/39 (2013.01) [A61K 9/0019 (2013.01); A61K 9/5031 (2013.01); A61K 39/0011 (2013.01); A61K 39/001106 (2018.08); A61K 39/00119 (2018.08); A61K 47/02 (2013.01); A61K 47/34 (2013.01); A61P 35/00 (2018.01); A61K 2039/5154 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55522 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/572 (2013.01); A61K 2039/6056 (2013.01); A61K 2039/812 (2018.08); A61K 2039/876 (2018.08)] | 10 Claims |
1. A device comprising:
a polymeric scaffold composition comprising mesoporous silica rods surface modified with a coating of polyethylenimine (PEI); and
a tumor antigen attached to the PEI,
wherein (i) the PEI does not interact with the tumor antigen to form a nanoparticle, and (ii) the PEI is not attached to CpG-ODN, poly(I:C), or poly(A:U), and
wherein the polymeric scaffold composition comprises open interconnected macropores having diameters of about 10 μm to about 600 μm.
|